Over the past two decades, the United States has been transitioning from cytology to HPV-based screening for cervical cancer. The U.S. Preventive Services Task Force currently recommends one of three options for routine cervical cancer screening: 1) cytology screening every three years; 2) HPV screening every five years; or 3) co-testing in which both an HPV and cytology screening are conducted every five years.